Arlet J-B, de Luna G, Khimoud D, et al. Prognosis of patients with sickle cell disease and COVID-19: a French experience. Lancet Haematol 2020; 7: e632–34—In the Declaration of interests section of this Comment, statements have been corrected for Jean-Benoît Arlet, Gonzalo de Luna, Mariane de Montalembert, Laure Joseph, Christelle Chantalat-Auger, and Pablo Bartolucci. These corrections have been made to the online version as of Aug 24, 2020.
. 2020 Aug 24;7(9):e635. doi: 10.1016/S2352-3026(20)30256-8
Correction to Lancet Haematol 2020; 7: e632–34
Issue date 2020 Sep.
© 2020 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC7445003 PMID: 32853580
This corrects the article "Prognosis of patients with sickle cell disease and COVID-19: a French experience" on page e632.